BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19003781)

  • 1. Pharmacokinetics of buccal mucosal administration of fentanyl in a carboxymethylcellulose gel compared with IV administration in dogs.
    Little AA; Krotscheck U; Boothe DM; Erb HN
    Vet Ther; 2008; 9(3):201-11. PubMed ID: 19003781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of transdermal morphine and fentanyl pluronic lecithin organogel administration in dogs.
    Krotscheck U; Boothe DM; Boothe HW
    Vet Ther; 2004; 5(3):202-11. PubMed ID: 15578452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of buprenorphine in a sodium carboxymethylcellulose gel after buccal transmucosal administration in dogs.
    Krotscheck U; Boothe DM; Little AA; Erb HN
    Vet Ther; 2010; 11(3):E1-8. PubMed ID: 20960411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose pharmacokinetics of fentanyl sublingual spray and oral transmucosal fentanyl citrate in healthy volunteers: a randomized crossover study.
    Parikh N; Goskonda V; Chavan A; Dillaha L
    Clin Ther; 2013 Mar; 35(3):236-43. PubMed ID: 23497761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers.
    Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
    Clin Ther; 2006 May; 28(5):707-14. PubMed ID: 16861092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics.
    Darwish M; Kirby M; Robertson P; Hellriegel E; Jiang JG
    Clin Pharmacokinet; 2006; 45(8):843-50. PubMed ID: 16884321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of fentanyl following intravenous and transdermal administration in horses.
    Maxwell LK; Thomasy SM; Slovis N; Kollias-Baker C
    Equine Vet J; 2003 Jul; 35(5):484-90. PubMed ID: 12875327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Pharmacokinet; 2005; 44(12):1279-86. PubMed ID: 16372825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute and relative bioavailability of fentanyl buccal tablet and oral transmucosal fentanyl citrate.
    Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
    J Clin Pharmacol; 2007 Mar; 47(3):343-50. PubMed ID: 17322146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of fentanyl after intravenous and transdermal administration in goats.
    Carroll GL; Hooper RN; Boothe DM; Hartsfield SM; Randoll LA
    Am J Vet Res; 1999 Aug; 60(8):986-91. PubMed ID: 10451210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of transdermally administered fentanyl in dogs.
    Kyles AE; Papich M; Hardie EM
    Am J Vet Res; 1996 May; 57(5):715-9. PubMed ID: 8723888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and dose selection of a novel, long-acting transdermal fentanyl solution in healthy laboratory Beagles.
    Freise KJ; Savides MC; Riggs KL; Owens JG; Newbound GC; Clark TP
    J Vet Pharmacol Ther; 2012 Aug; 35 Suppl 2():21-6. PubMed ID: 22731772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of subcutaneous fentanyl in Greyhounds.
    KuKanich B
    Vet J; 2011 Nov; 190(2):e140-e142. PubMed ID: 21388844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and the effect of application site on a novel, long-acting transdermal fentanyl solution in healthy laboratory Beagles.
    Freise KJ; Newbound GC; Tudan C; Clark TP
    J Vet Pharmacol Ther; 2012 Aug; 35 Suppl 2():27-33. PubMed ID: 22731773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose pharmacokinetics of fentanyl buccal soluble film.
    Vasisht N; Gever LN; Tagarro I; Finn AL
    Pain Med; 2010 Jul; 11(7):1017-23. PubMed ID: 20492573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between plasma concentrations and analgesia after intravenous fentanyl and disposition after other routes of administration in cats.
    Robertson SA; Taylor PM; Sear JW; Keuhnel G
    J Vet Pharmacol Ther; 2005 Feb; 28(1):87-93. PubMed ID: 15720520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetics of intravenous fentanyl and buprenorphine in healthy greyhound dogs.
    KuKanich B; Allen P
    J Vet Pharmacol Ther; 2014 Dec; 37(6):595-7. PubMed ID: 24684621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of fentanyl after single intravenous injection and constant rate infusion in dogs.
    Sano T; Nishimura R; Kanazawa H; Igarashi E; Nagata Y; Mochizuki M; Sasaki N
    Vet Anaesth Analg; 2006 Jul; 33(4):266-73. PubMed ID: 16764592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of fentanyl buccal tablet: a pooled analysis and review.
    Darwish M; Xie F
    Pain Pract; 2012 Apr; 12(4):307-14. PubMed ID: 21831253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.